A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

Besides the flu, other respiratory viruses such as respiratory syncytial virus (RSV) and COVID also tend to peak during the ...

COVID-19 antivirals, specifically, have become hard to access for some patients. Many requirements accompany the distribution of the drugs to patients, and for a good reason. Accessing antivirals ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...

If the test is positive, contact your doctor so you can get the appropriate treatment—which is sometimes a prescription for ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...